Daniel Janney

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Jackson, WY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Krish Krishnan, as attorney-in-fact for Daniel Janney
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Daniel Janney

Form 4 holding Director

Krystal Biotech, Inc.

Security class
Common Stock
Shares / value
73,293
Estimated value
$20,241,071
Report date
27 Feb 2026
Price
$276.17
Ownership
Directly beneficially owned by Alta Bioequities, L.P.
Form 4 holding Director

Esperion Therapeutics, Inc.

Security class
Common Stock
Shares / value
24,565
Estimated value
$30,583
Report date
27 May 2021
Price
$1.24
Ownership
By Alta Bioequities, L.P.
Form 4 holding Director

Allakos Inc.

Security class
Stock Option (Right to buy)
Shares / value
86,762
Estimated value
Report date
25 May 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Daniel Janney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .